Why Zscaler Stock Rocketed Higher This Week
Source: Nasdaq

Zscaler shares rose 20.7% from last Friday through 3:37 p.m. following Bernstein's reiteration of an outperform rating and price-target increase to $298 from $224. The new target implies 56% upside from Zscaler's $191.58 Wednesday close, with Bernstein citing improving cybersecurity-sector sentiment and Zscaler's remaining valuation upside. The stock trades at 25.8x operating cash flow, well below its five-year average of 47.6x, although Wedbush recently cut its target to $215 from $220.
Analysis
The sharp repricing is primarily a positioning and multiple-normalization event, not evidence of a revised earnings-power trajectory. ZS is a high-duration security asset; after a 20% move, the near-term asymmetry worsens unless upcoming billings, remaining performance obligations, and large-enterprise deal commentary validate reacceleration. The key transmission channel is whether investors rotate within cyber toward platform vendors with visible growth durability, potentially pressuring relative performance in PANW, CRWD and FTNT rather than expanding the entire sector's valuation envelope.
Over the next 1-3 months, the catalyst is consensus upward revisions to FY revenue growth, operating margin, and free-cash-flow conversion—not additional target-price changes. ZS must demonstrate that zero-trust consolidation is translating into net-new spend rather than license displacement from VPN/SWG incumbents; otherwise, its apparent cash-flow multiple discount is justified by decelerating growth and stock-based-compensation dilution. A weaker-than-expected federal demand environment, elongated large-deal cycles, or guidance that implies billings growth below peer levels would quickly unwind a sentiment-driven advance.
Contrarian view: the market may be underestimating the strategic value of ZS's architecture if AI-driven identity, data and workload traffic expands the addressable policy-enforcement layer. But it may also be overestimating the value of historical valuation comparisons: mature SaaS assets should not automatically regain prior-cycle multiples when rates, competitive intensity and customer procurement scrutiny remain structurally different. Monitor the ZS/CRWD relative ratio after this move; sustained outperformance requires fundamental estimate dispersion to close, not merely a sell-side endorsement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
Key Decisions for Investors
- Do not chase ZS immediately after the sentiment-led gap; establish a 1-2% starter only on consolidation or ahead of earnings if channel checks support large-deal conversion. Add only if next guidance raises implied forward billings/revenue expectations; exit if management signals further deal-cycle elongation.
- Run a 1-3 month relative-value expression: long ZS / short FTNT in equal dollar amounts, conditional on ZS maintaining post-rally support. ZS has greater upside to zero-trust platform reacceleration, while FTNT is more exposed to hardware refresh and lower-growth valuation compression; stop if FTNT delivers a material billings reacceleration or ZS cuts growth expectations.
- For defined-risk upside, consider ZS call spreads 3-6 months out rather than outright calls, financed only after implied volatility is checked against its one-year range. Target a further estimate-driven rerating; cap exposure because a single weak billings print can produce a high-teens drawdown in long-duration software.
- Watch PANW, CRWD and ETF HACK for corroboration. If those peers fail to participate despite ZS strength, treat the move as idiosyncratic short-covering and reduce exposure; broad peer estimate upgrades would support a sector allocation rather than a single-name trade.
More News
- Anthropic selects Accenture as first embedded evaluator to help implement Amodei's slowdown proposal
- Anthropic and OpenAI hunt for smaller data center deals, sources tell CNBC, in race to deploy AI capacity
- The U.S. says China's AI progress is down to 'distillation.' But is it that clear cut?
- Take Five: High stakes, low bars
- Netflix is headed for its worst year since 2022. Wells Fargo thinks a comeback is unlikely
- Why Twist Bioscience Stock Skyrocketed This Week